ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryNyonHartis-Pharma SA
Hartis-Pharma SA Logo
Verified· 2 sources

Hartis-Pharma SA

Summary

About the company

The core activity of HARTIS Pharma consists of researching and developing therapeutics based on the potential benefits of High-Density-Lipoprotein (HDL), particularly through the regulation of membrane cholesterol and its liposoluble cargo activity of antioxidants. The company focuses on developing treatments for medical needs that have not been adequately addressed or cannot be treated sufficiently.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Development of therapeutics for sickle cell disease
Development of oral and injectable active ingredients for the treatment of sickle cell disease, including HRT-001 for chronic SCD and HRT-002 for vaso-occlusive crises.
Development of HDL-based therapies
Revisiting the therapeutic potential of HDL to regulate cholesterol in the red blood cell membrane as well as to reduce oxidation and hemoglobin polymerisation.
Development of therapies for sickle cell trait and related pathologies
Investigation of potential therapeutic approaches for sickle cell trait as well as applications in thalassaemia, microcirculation and type 2 diabetes.
Development of antioxidant and lipophilic vitamin transport therapies
Transport of liposoluble vitamins and antioxidants with possible applications in skin conditions, age-related macular degeneration, Alzheimer and neurodegenerative diseases.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Knowledge

No knowledge articles yet

Once Hartis-Pharma SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Hartis-Pharma SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Hartis-Pharma SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Hartis-Pharma SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin de Bonmont 13 C
1260 Nyon

At a glance

Legal form
Corporation
UID
CHE-293.248.994
Founded
2018 · 8 years
Last commercial register change
May 18, 2018
Employees
11 to 20

Similar companies

ES
EFFIK SA
Nyon
LL
LRK Laboratoire homéopathique de recherches Kurtoglu SA
Cugy Vd
OS
Oligopharm SA
Cugy Vd
IB
Incyte Biosciences International Sàrl
Morges